Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
The collaboration will establish a platform for leukaemia and other cancer treatments within the Middle East and Africa.
Cytiva Pipe dream to pipeline WP 3
Harbour BioMed partners Otsuka on new T-cell therapy
NSW government invests $13.39m in life-changing therapies
Sarepta and Roche halt DMD gene therapy’s use in certain patients after second death
FDA approves Capsida’s CAP-003 gene therapy for Parkinson’s
SpliceBio secures $135m for gene therapy development
FDA grants RMAT designation to AbelZeta’s CAR-T therapy
AGC Biologics and Quell to progress Treg cell therapy development
